Interaction between uric acid and endothelial dysfunction predicts new onset of diabetes in hypertensive patients

International Journal of Cardiology

Volumn 167, Issue 1, 2013, Pages 232-236

  Perticone, Francesco ^a   Maio, Raffaele ^a   Tassone, Joseph E ^a   Perticone, Maria ^a   Pascale, Alessandra ^a   Sciacqua, Angela ^a   Sesti, Giorgio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Cardiovascular risk factors; Diabetes; Endothelial dysfunction; Uric acid

Indexed keywords

C REACTIVE PROTEIN; INSULIN; URIC ACID;

ADULT; AGE; ARTICLE; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; FOREARM BLOOD FLOW; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLETHYSMOGRAPHY; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

ADULT; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; URIC ACID; VASODILATION;

EID: 84878546334     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.12.065     Document Type: Article

References (39)

1. F. Facchini, Y.D. Chen, C.B. Hollenbeck, and G.M. Reaven Relationship between resistance to insulin mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration JAMA 266 1991 3008 3011
2. B.F. Culleton, M.G. Larson, W.B. Kannel, and D. Levy Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study Ann Intern Med 131 1999 7 13
3. D.I. Feig, and R.J. Johnson Hyperuricemia in childhood primary hypertension Hypertension 42 2003 247 252
4. H.K. Choi, K. Atkinson, E.W. Karlson, and G. Curhan Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow up study Arch Intern Med 165 2005 742 748
5. D.I. Feig, D.H. Kang, and R.J. Johnson Uric acid and cardiovascular risk N Engl J Med 359 2008 1811 1821
6. D.I. Feig, B. Soletsky, and R.J. Johnson Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial JAMA 300 2008 924 932
7. Y. Tavil, M.G. Kaya, and S.O. Oktar Uric acid level and its association with carotid intima-media thickness in patients with hypertension Atherosclerosis 197 2008 159 163
8. L. Pacifico, V. Cantisani, and C. Anania Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children Eur J Endocrinol 160 2009 45 52
9. T. Neogi, R.C. Ellison, S. Hunt, R. Terkeltaub, D.T. Felson, and Y. Zhang Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study J Rheumatol 36 2009 378 384
10. B.P. Wiik, A.C.K. Larstorp, and A. Høieggen Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: the LIFE Study Am J Hypertens 23 2010 845 851
11. A. So, and B. Thorens Uric acid transport and disease J Clin Invest 120 2010 1791 1799
12. A. Dehghan, M. vanHoek, E.J. Sijbrands, A. Hofman, and J.C. Witteman High serum acid as a novel risk factor for type 2 diabetes Diabetes Care 31 2008 361 362
13. R. Butler, A.D. Morris, J.J. Belch, A. Hill, and A.D. Struthers Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension Hypertension 35 2000 746 751
14. T. Nakagawa, H. Hu, and S. Zharikov A causal role for uric acid in fructose-induced metabolic syndrome Am J Physiol Renal Physiol 290 2006 F625 F631
15. J.R. Vane, E.E. Anggard, and R.M. Botting Regulatory functions of the vascular endothelium N Engl J Med 323 1990 27 36
16. T.F. Lüscher, and P.M. Vanhoutte The endothelium: modulator of cardiovascular function 1990 Boca Raton, FL CRC Press
17. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 334 1998 1349 1357
18. J.A. Suwaidi, S. Hamasaki, S.T. Higano, R.A. Nishimura, D.R. Olmes Jr., and A. Lerman Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction Circulation 101 2000 948 954
19. V. Schächinger, M.B. Britten, and A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
20. T. Heitzer, T. Schlinzig, H. Krohn, T. Meinertz, and T. Munzel Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease Circulation 104 2001 2673 2678
21. J.P. Halcox, W.H. Schenke, and G. Zalos Prognostic value of coronary vascular endothelial dysfunction Circulation 106 2002 653 658
22. F. Perticone, R. Ceravolo, and A. Pujia Prognostic significance of endothelial dysfunction in hypertensive patients Circulation 104 2001 191 196
23. C. Zoccali, R. Maio, F. Mallamaci, G. Sesti, and F. Perticone Uric acid and endothelial dysfunction in essential hypertension J Am Soc Nephrol 17 2006 1466 1471
24. F. Perticone, R. Maio, and A. Sciacqua Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension Diabetes 57 2008 167 171
25. The Expert Committee on the diagnosis and classification of diabetes mellitus: report of the Expert Committee on the diagnosis and classification of diabetes mellitus Diabetes Care 20 1997 1183 1197
26. A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
27. J.A. Panza, A.A. Quyyumi, J.E. Brush, and S.E. Epstein Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension N Engl J Med 323 1990 22 27
28. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostatic model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
29. D.G. Altman Practical statistics for medical research first edition 1991 Chapman and Hall Edition London UK
30. G. Mercuro, C. Vitale, E. Cerquetani, S. Zoncu, M. Deidda, M. Fini, and G.M. Rosano Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk Am J Cardiol 94 2004 932 935
31. J. Kanellis, and D.H. Kang Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease Semin Nephrol 25 2005 39 42
32. D.H. Kang, S.K. Park, I.K. Lee, and R.J. Johnson Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells J Am Soc Nephrol 16 2005 3553 3562
33. F. Cosentino, K. Hishikawa, Z.S. Katusic, and T.F. Lüscher High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells Circulation 96 1997 25 28
34. F. Perticone, A. Sciacqua, and R. Maio Asymmetric dimethylarginine, l-arginine, and endothelial dysfunction in essential hypertension J Am Coll Cardiol 46 2005 518 523
35. J. Kanellis, S. Watanabe, and J.H. Li Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein Hypertension 41 2003 1287 1293
36. Y.Y. Sautin, T. Nakagawa, S. Zharikov, and R.J. Johnson Adverse effects of the classical antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress Am J Physiol Cell Physiol 293 2007 C584 C596
37. D.B. Corry, P. Eslami, K. Yamamoto, M.D. Nyby, H. Makino, and M.L. Tuck Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system J Hypertens 26 2008 269 275
38. G.N. Rao, M.A. Corson, and B.C. Berk Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression J Biol Chem 266 1991 8604 8608
39. D.H. Kang, T. Nakagawa, and L. Feng A role for uric acid in the progression of renal disease J Am Soc Nephrol 13 2002 2888 2897